Low Vision Writing Paper with Bold Lines - 8.5" x 11" Single Pad

Low Vision Writing Paper - Bold Line -1 pad

by MaxiAids

$4.95

Ready to use This is paper — open and use immediately with zero setup, pairing, or configuration. Self_serve is unambiguous here.

Last verified June 17, 2026 · classified April 26, 2026

What it is

Summary

AI-generated from vendor-published content · April 26, 2026

This is a standard letter-size writing pad printed with thick, high-contrast black lines spaced about three-quarters of an inch apart — much bolder and wider than regular ruled paper. It's designed for people with low vision who have difficulty seeing faint or closely-spaced lines, making it easier to write legibly and stay within lines without magnification. You get a complete, ready-to-use pad of 100 sheets — no setup required. The lines are printed on both sides, and the sheets have no holes, so they won't fit in a standard three-ring binder without a hole punch.

Quick Facts Catalog facts · auto-generated
Age range
ComplexityReady to use
Price$4.95
Funding
  • AT Act lending
  • Out of pocket
  • School district
VerifiedJune 17, 2026
ClassifiedApril 26, 2026 · confidence: high

What Setup Looks Like

  • Out of the box
    Remove sheets from the pad and write directly on the bold-lined paper — no preparation needed.

Getting it

Try Before You Buy

Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.

Where to Get It

maxiaids Visit
$4.95

Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →

As an Amazon Associate we earn from qualifying purchases.

Wondering how equipment like this gets paid for? See the official funding programs in your state.

Sources & fine print

Vendor facts (name, price, platforms, vendor link) sourced from MaxiAidsview on vendor site; last verified June 17, 2026.

Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.